VIR vs. VERU
Compare and contrast key facts about Vir Biotechnology, Inc. (VIR) and Veru Inc. (VERU).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VIR or VERU.
Correlation
The correlation between VIR and VERU is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VIR vs. VERU - Performance Comparison
Key characteristics
VIR:
-0.48
VERU:
-0.27
VIR:
-0.48
VERU:
0.42
VIR:
0.95
VERU:
1.06
VIR:
-0.45
VERU:
-0.32
VIR:
-1.36
VERU:
-0.57
VIR:
31.21%
VERU:
54.52%
VIR:
88.17%
VERU:
115.86%
VIR:
-93.28%
VERU:
-98.44%
VIR:
-93.28%
VERU:
-97.60%
Fundamentals
VIR:
$765.26M
VERU:
$83.41M
VIR:
-$3.83
VERU:
-$0.21
VIR:
$16.73M
VERU:
$10.61M
VIR:
$11.69M
VERU:
$4.03M
VIR:
-$462.00M
VERU:
-$29.34M
Returns By Period
In the year-to-date period, VIR achieves a -23.98% return, which is significantly lower than VERU's -12.41% return.
VIR
-23.98%
-32.12%
-27.91%
-41.08%
-28.14%
N/A
VERU
-12.41%
8.55%
-25.99%
-31.35%
-28.35%
-15.90%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VIR vs. VERU — Risk-Adjusted Performance Rank
VIR
VERU
VIR vs. VERU - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vir Biotechnology, Inc. (VIR) and Veru Inc. (VERU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VIR vs. VERU - Dividend Comparison
Neither VIR nor VERU has paid dividends to shareholders.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
VIR Vir Biotechnology, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VERU Veru Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.57% |
Drawdowns
VIR vs. VERU - Drawdown Comparison
The maximum VIR drawdown since its inception was -93.28%, smaller than the maximum VERU drawdown of -98.44%. Use the drawdown chart below to compare losses from any high point for VIR and VERU. For additional features, visit the drawdowns tool.
Volatility
VIR vs. VERU - Volatility Comparison
The current volatility for Vir Biotechnology, Inc. (VIR) is 16.39%, while Veru Inc. (VERU) has a volatility of 34.49%. This indicates that VIR experiences smaller price fluctuations and is considered to be less risky than VERU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
VIR vs. VERU - Financials Comparison
This section allows you to compare key financial metrics between Vir Biotechnology, Inc. and Veru Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities